fmr. fda chief dr. scott gottlieb: it was 'prudent' to pause j&j vaccine
Published 3 years ago • 7.2K plays • Length 4:32Download video MP4
Download video MP3
Similar videos
-
3:50
dr. scott gottlieb: don't 'overinterpret' decision to pause j&j vaccine over rare clotting issue
-
4:02
dr. scott gottlieb discusses effectiveness of j&j covid-19 vaccine
-
4:53
fmr. fda chief scott gottlieb on global vaccine distribution
-
36:31
watch live: former fda officials dr. scott gottlieb and dr. luciana borio in cnbc’s healthy returns
-
3:39
fmr. fda chief dr. scott gottlieb: the issue isn't just vaccine hesitancy, but accessibility
-
5:01
fmr. fda chief says he expects covid-19 vaccine shortage to continue past next week
-
4:13
fda asks vaccine makers to create covid boosters targeting omicron subvariants
-
12:07
why the flu season will be a ‘whopper’: former fda chief scott gottlieb
-
5:13
former fda chief scott gottlieb on why the public can trust the vaccine approval process
-
4:52
former fda chief scott gottlieb on j&j's application for emergency use authorization
-
4:40
former fda chief gottlieb: covid vaccine reduces transmission, but question is how much
-
3:13
for fda chief scott gottlieb: j&j covid vaccine should work against delta variant
-
3:22
former fda chief dr. scott gottlieb makes the case for vaccine passports
-
6:54
dr. scott gottlieb on j&j vaccine trial results, covid mutations and more
-
5:08
fmr. fda chief dr. scott gottlieb discusses potential covid 'usa variant'
-
6:11
dr. scott gottlieb: people need to be prudent, even if they're vaccinated
-
7:28
coronavirus: congress must act fast to mitigate the pandemic, fda commissioner says
-
5:36
gottlieb: fda's new guidelines are in line with expectations
-
4:45
former fda chief scott gottlieb on russia's covid-19 vaccine claims
-
4:29
fmr. fda chief scott gottlieb: may need revaccination for covid from time to time
-
4:54
fmr. fda chief: covid-19 vaccine recipients shouldn't let their guards down right away
-
4:26
need to find source of spread, we're not shutting down again: fmr. fda chief